Skip to main content
SpringerLink
Log in

Dopamine

  • Chapter
Neurotransmitters and Drugs

Abstract

Dopamine is a catecholamine neurotransmitter in the central nervous system (CNS) and at some ganglia in the autonomic nervous system; most of our knowledge of the functional role of dopamine relates to the CNS. In both the peripheral and central nervous system, dopamine is a precursor of noradrenaline and adrenaline.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  • Kebabian, J.W. and Calne, D.B. (1979) Multiple dopamine receptors. Nature, 277, 93–96.

    Article  PubMed  CAS  Google Scholar 

  • Kopin, I.J. and Markey, S.P. (1988) MPTP toxicity: Implication for research in Parkinson’s disease. Ann. Res. Neurosci., 11, 81–96.

    Article  CAS  Google Scholar 

  • Langston, J.W. and Irwin, I. (1986) MPTP current concepts and controversies. Clin. Neuropharmacol., 9, 485–507.

    Article  PubMed  CAS  Google Scholar 

  • Lees, A.J. (1986) L-DOPA treatment and Parkinson’s disease. Q. J. Med., 59, 535–547.

    PubMed  CAS  Google Scholar 

  • McGeer, E.G., Staines, W.A. and McGeer, P.L. (1984) Neurotransmitters in the basal ganglia. Can. J. Neurolog. Sci., 11, suppl., 89–99.

    CAS  Google Scholar 

  • Marsden, C.D. (1990) Parkinson’s disease. Lancet, 948–952.

    Google Scholar 

  • Penney, J.B. and Young, A.B. (1983) Speculations on the functional anatomy of basal ganglia disorders. Ann. Rev. Neurosci., 6, 73–94.

    Article  PubMed  Google Scholar 

  • Sokoloff, P., Giros, B., Martes, M-P., Bouthenet, M-L. and Schwartz, J-C. (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature, 347, 146–151.

    Article  PubMed  CAS  Google Scholar 

  • Tanner, C.M. (1989) The role of environmental toxins in the aetiology of Parkinson’s disease. Trends Neurosci., 12, No. 2.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology Queen Mary and Westfield College, University of London, UK

    Zygmunt L. Kruk (Reader in Neuropharmacology)

  2. Derriford Hospital, Plymouth, UK

    Christopher J. Pycock (Senior Registrar in General Medicine)

Authors
  1. Zygmunt L. Kruk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christopher J. Pycock
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Zygmunt L. Kruk and Christopher J. Pycock

About this chapter

Cite this chapter

Kruk, Z.L., Pycock, C.J. (1991). Dopamine. In: Neurotransmitters and Drugs. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3134-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3134-6_4

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-412-36110-4

  • Online ISBN: 978-94-011-3134-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation